NCT00458107View on ClinicalTrials.gov

Study Evaluating the Safety and Tolerability of SCA-136 in Healthy Japanese and Non-Japanese Female Subjects

PHASE1CompletedINTERVENTIONAL
Enrollment

64

Participants

Timeline

Start Date

April 30, 2007

Study Completion Date

September 30, 2007

Conditions
Schizophrenia
Interventions
DRUG

SCA-136

Trial Locations (1)

91206

Glendale

All Listed Sponsors
lead

Wyeth is now a wholly owned subsidiary of Pfizer

INDUSTRY

NCT00458107 - Study Evaluating the Safety and Tolerability of SCA-136 in Healthy Japanese and Non-Japanese Female Subjects | Biotech Hunter | Biotech Hunter